期刊
BLOOD ADVANCES
卷 5, 期 16, 页码 3216-3226出版社
ELSEVIER
DOI: 10.1182/bloodadvances.2021004201
关键词
-
类别
资金
- National Institutes of Health National Heart, Lung, and Blood Institute [K08 HL132101]
- Department of Defense [BM170031]
- Institute for Translational Medicine and Therapeutics of the Perelman School of Medicine at the University of Pennsylvania
- National Institutes of Health National Center for Advancing Translational Sciences [UL1TR001878]
Acquired aplastic anemia (AA) and inherited bone marrow failure syndromes (IBMFSs) require accurate and prompt diagnosis for optimal patient outcomes. Laboratory findings specific to the autoimmune pathogenesis of AA, including paroxysmal nocturnal hemoglobinuria (PNH) and acquired 6p CN-LOH clones, effectively distinguish AA from IBMFSs and should be used in diagnostic evaluation.
Acquired aplastic anemia (AA) is a life-threatening bone marrow aplasia caused by the autoimmune destruction of hematopoietic stem and progenitor cells. There are no existing diagnostic tests that definitively establish AA, and diagnosis is currently made via systematic exclusion of various alternative etiologies, including inherited bone marrow failure syndromes (IBMFSs). The exclusion of IBMFSs, which requires syndrome-specific functional and genetic testing, can substantially delay treatment. AA and IBMFSs can have mimicking clinical presentations, and their distinction has significant implications for treatment and family planning, making accurate and prompt diagnosis imperative to optimal patient outcomes. We hypothesized that AA could be distinguished from IBMFSs using 3 laboratory findings specific to the autoimmune pathogenesis of AA: paroxysmal nocturnal hemoglobinuria (PNH) clones, copy-number-neutral loss of heterozygosity in chromosome arm 6p (6p CN-LOH), and clonal T-cell receptor (TCR) gamma gene (TRG) rearrangement. To test our hypothesis, we determined the prevalence of PNH, acquired 6p CN-LOH, and clonal TRG rearrangement in 454 consecutive pediatric and adult patients diagnosed with AA, IBMFSs, and other hematologic diseases. Our results indicated that PNH and acquired 6p CN-LOH clones encompassing HLA genes have similar to 100% positive predictive value for AA, and they can facilitate diagnosis in approximately one-half of AA patients. In contrast, clonal TRG rearrangement is not specific for AA. Our analysis demonstrates that PNH and 6p CN-LOH clones effectively distinguish AA from IBMFSs, and both measures should be incorporated early in the diagnostic evaluation of suspected AA using the included Bayesian nomogram to inform clinical application.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据